Pyxis Oncology grabs $152m Series B

Pyxis Oncology, a provider of biologics, has secured $152 million in Series B financing.

Pyxis Oncology, a provider of biologics, has secured $152 million in Series B financing. Arix Bioscience and RTW Investments led the round.

Source: Press Release